Psymposium Madrid 2025 presents a three-day forum (October 2–4, 2025) dedicated to mental health innovation, neuroscience, and psychedelic-assisted therapy. Hosted in the Gran Anfiteatro of the Ilustre Colegio de Médicos de Madrid, the gathering aims to advance discussion ahead of World Mental Health Day.
The opening day supplies context: historical perspectives on psychedelic use, current pharmacology, and recent findings in neurobiology. Day two presents clinical trial updates, therapist–patient dialogues, and case studies on disorders such as depression, PTSD, and substance-use conditions. The final day turns to future directions, examining virtual-reality integrations and the evolving legislative landscape in Spain and Latin America for psychedelic-assisted treatments.
Confirmed speakers include Dr David Erritzøe (Imperial College London), Marcela Ot’alora (MAPS), Dr José Carlos Bouso (ICEERS), Dr Liliana Galindo (University of Cambridge), Christopher Timmermann, Débora González, Magí Farré, and Rosa María Dueñas. Their combined expertise spans basic research, clinical practice, and policy analysis, ensuring a rounded examination of the field.
Attendance is limited to 450 participants. Professionals interested in current and emerging approaches to mental health care may find the discussions and networking opportunities valuable.
Find out more about Inawe Psymposium 2025
Type of Event: Conference
Audience: Academic General Population
Dates: 02 - 04 October 2025
Price: $ 17 - 300